Roncaroli et al.
The vasodilatory action of NP can be observed on the
minute time scale after injection. It can be inferred that free
NO must be generated in solution in order to activate soluble
guanylate cyclase (sGC) to trigger the vasodilation process.1
Activation involves a very fast (ca. 108 M-1 s-1) coordination
of at least one NO ligand at the iron center of the enzyme.8
The mechanism by which the NO+ ligand in NP is reduced
and released into bodily fluids has not been clearly defined
in the literature.1,9 It can reasonably be presumed that
thiolates or other biologically relevant reductants may be
operative at the beginning, but the chemistry of the reduction
product(s) is still unclear, particularly those aspects dealing
with the rates of dissociation of NO from iron.9 It is known
that the NO ligand generally promotes ligand labilization at
the trans position,2,3 and this is the case with reaction 1 for
[Fe(CN)5NO]3-
NO vs cyanides from reduced NP is particularly intriguing
as is the ensuing fate of NO in the solution. The possibility
of further reactivity, other than its eventual coordination to
heme proteins (e.g., sGC), should also be considered.
In the studies of coordination of NO to the [FeII(CN)5H2O]3-
ion at pH 7, we found that the initial product [Fe(CN)5NO]3-
was unstable under an excess of NO.13 A prelim-
inary investigation revealed that [Fe(CN)4NO]2-, not
[Fe(CN)5NO]3-, was the active species promoting decom-
position and that NP was formed as one of the products.
This result suggested that an NO-disproportionation process
could be involved. We, herein, present the results of a
stoichiometric and kinetic study in the pH range of 4-10
centered on the spontaneous decay of [FeII(CN)5NO]3- and/
or [Fe(CN)4NO]2- using UV-vis, IR, EPR, electrochemical,
and mass-spectrometric techniques. The study involves
avoiding light exposure1,4 and maintaining anaerobic condi-
tions. The latter is important because [FeII(CN)5NO]3- can
be rapidly transformed back to NP in aerobic media.14 Our
studies can be placed in the context of the still underdevel-
oped chemistry of bound NO in transition metal complexes;15
we address specifically the nitrosyl transfer problem from a
M-NO donor (viz., NP) to another metal acceptor,16 and
we include the possible intermediacy of dinitrosyl com-
pounds.
k1
[Fe(CN)5NO]3-
{
} [Fe(CN)4NO]2- + CN-
(1)
k-1
The equilibrium in reaction 1 is rapidly established in
solution with k1 ) 2.7 × 102 s-1 and k-1 ) 4 × 106 M-1 s-1
at 25.0 °C.10 The predominance of [Fe(CN)5NO]3- or
[Fe(CN)4NO]2- is strongly pH-dependent, and the relative
concentration of the latter species increases with decreasing
pH. Both anionic species have been obtained as solid salts
and characterized spectroscopically, including structural
results for [Fe(CN)4NO]2-.10,11 Although it has long been
recognized that [Fe(CN)5NO]3- is inert for the release of
NO,12 the NO-dissociation rate constant has only recently
been measured (k-NO ) 1.6 × 10-5 s-1, 25.0 °C).13 Con-
sequently, the rapid delivery of NO in the biological media
has been frequently ascribed to the labile [Fe(CN)4NO]2-
ion with the additional proposal that the remaining cyanides
are subsequently released.12 No kinetic evidence has been
provided for these processes. The timing of the release of
Experimental Section
General Procedures. All chemicals were of analytical grade and
were used without further purification. Eighty-five percent sodium
dithionite (Na2S2O4) was from Acros. Acetate, bis-tris or phosphate,
and borate buffers were used with NaCl to adjust the ionic strength.
The pH measurements in the range of 4-10 were done at room
temperature with a 744 Metrohm pH meter. The preparation of the
solutions was done in Schlenk tubes. The amount of the reducing
agent, usually sodium dithionite (Na2S2O4) or sodium tetrahydro-
borate (NaBH4), necessary for the reaction was added as a solid to
N2- or Ar-saturated solutions of NP containing the appropriate buffer
and ionic strength. At least a 2-fold excess of NP over the reducing
agent was always employed. The solutions were always protected
from light and were transferred using gastight syringes and a
vacuum/Ar or N2 line. NO was purchased from Air Liquide and
purified from higher nitrogen oxides by passing them through an
ascarite II column. The concentration of NO in the saturated
solutions prepared under NO bubbling was 1.8 mM.
Stoichiometric and Kinetic Results. (a) Chemical Analysis
of Reactants and Ionic Products. NP (2-3.5 mg) was dissolved
in 10 mL of a 0.01 M buffer solution (I ) 0.1 M, NaCl). Na2S2O4
was added, and an aliquot was immediately transferred to a
spectrophotometric cell to record the UV-vis spectrum. The initial
concentration of the reduced NP species, either [Fe(CN)5NO]3- or
[Fe(CN)4NO]2-, was calculated considering the molar absorbance
values reported in the literature10 (these values were also checked
experimentally in this study). The concentrations usually ranged
between 0.2 and 0.5 mM. The samples were allowed to react for 2
(8) Ballou, D. P.; Zhao, Y.; Brandish, P. E.; Marletta, M. A. Proc. Natl.
Acad. Sci. U.S.A. 2002, 99, 12097-12101.
(9) Butler, A. R.; Calsy-Harrison, A. M.; Glidewell, C.; Sorensen, P. E.
Polyhedron 1988, 7, 1197-1202.
(10) Cheney, R. P.; Simic, M. G.; Hoffman, M. Z.; Taub, I. A.; Asmus, K.
D. Inorg. Chem. 1977, 16, 2187-2192.
(11) (a) Nast, R.; Schmidt, J. Angew. Chem., Int. Ed. Engl. 1969, 8, 383.
(b) van Voorst, J. D. W.; Hemmerich, P. J. Chem. Phys. 1966, 45,
3914-3918. (c) Schmidt, J.; Ku¨hr, H.; Dorn, W. L.; Kopf, J. Inorg.
Nucl. Chem. Lett. 1974, 10, 55-61. (d) Glidewell, C.; Johnson, I. L.
Inorg. Chim. Acta 1987, 132, 145-147.
(12) (a) Butler, A. R.; Glidewell, C.; Johnson, I. L.; McIntosh, A. S. Inorg.
Chim. Acta 1987, 138, 159-162. (b) Shafer, P. R.; Wilcox, D. E.;
Kruszyna, H.; Kruszyna, R.; Smith, R. P. Toxicol. Appl. Pharmacol.
1989, 99, 1-10. (c) Wilcox, D. E.; Kruszyna, H.; Kruszyna, R.; Smith,
R. P. Chem. Res. Toxicol. 1990, 3, 71-76. (d) Bates, J. N.; Baker, M.
T.; Guerra, R., Jr.; Harrison, D. G. Biochem. Pharmacol. 1991, 42,
S157-S165. (e) Kruszyna, H.; Kruszyna, R.; Rochelle, L. G.; Smith,
R. P.; Wilcox, D. E. Biochem. Pharmacol. 1993, 46, 95-102.
(f) Rochelle, L. G.; Kruszyna, H.; Kruszyna, R.; Barchowsky, A.;
Wilcox, D. E.; Smith, R. P. Toxicol. Appl. Pharmacol. 1994, 128,
123-128.
(13) (a) Roncaroli, F.; Olabe, J. A.; van Eldik, R. Inorg. Chem. 2003, 42,
4179-4189. (b) Values of NO-dissociation rate constants are very
scarce in the literature. By comparison with the dissociation rates of
other L ligands in the [FeII(CN)5L]3- complexes, NO was shown to
be more labile than the strong π-acceptor NO+ (k-NO+ cannot be
measured from NP) but more inert than NH3, a σ-only ligand. We
infer that an intermediate σ-π binding of NO to Fe(II), of comparable
magnitude to the one for pyrazine or dimethyl sulfoxide, is established.
(14) Morando, P. J.; Borghi, E. B.; Schteingart, L. M.; Blesa, M. A. J.
Chem. Soc., Dalton Trans. 1981, 435-440.
(15) (a) Ford, P. C.; Lorkovic, I. M. Chem. ReV. 2002, 102, 993-1018.
(b) Ford, P. C.; Laverman, L. E.; Lorkovic, I. M. AdV. Inorg. Chem.
2003, 54, 203-257.
(16) Ueno, T.; Suzuki, Y.; Fujii, S.; Vanin, A. F.; Yoshimura, T. Biochem.
Pharmacol. 2002, 63, 485-493.
2782 Inorganic Chemistry, Vol. 44, No. 8, 2005